Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 209,973,131 papers from all fields of science
Search
Sign In
Create Free Account
B 669
Known as:
2-Phenazinamine, 3-(cyclohexylimino)-3,5-dihydro-N,5-diphenyl-
, B-669
, B669
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Clofazimine
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
Inhibition of potassium transport and growth of mycobacteria exposed to clofazimine and B669 is associated with a calcium-independent increase in microbial phospholipase A2 activity.
H. Steel
,
N. M. Matlola
,
R. Anderson
Journal of Antimicrobial Chemotherapy
1999
Corpus ID: 38031630
Altered phospholipase A2 (PLA2) activity and its relationship to cation (K+, Ca2+) uptake and growth were investigated in…
Expand
1998
1998
Alpha-tocopherol antagonizes the multidrug-resistance-reversal activity of cyclosporin A, verapamil, GF120918, clofazimine and B669.
C. V. van Rensburg
,
G. Jooné
,
R. Anderson
Cancer Letters
1998
Corpus ID: 38292599
1996
1996
The riminophenazines, clofazimine and B669, inhibit potassium transport in gram-positive bacteria by a lysophospholipid-dependent mechanism.
E. E. de Bruyn
,
H. Steel
,
E. J. van Rensburg
,
R. Anderson
Journal of Antimicrobial Chemotherapy
1996
Corpus ID: 43426202
The effects of the riminophenazine antimicrobial agents clofazimine and B669 as well as those of lysophosphatidylcholine (LPC…
Expand
1995
1995
The inhibitory effects of Mycobacterium tuberculosis on MHC class II expression by monocytes activated with riminophenazines and phagocyte stimulants
A. Wadee
,
R. Kuschke
,
T. Dooms
Clinical and Experimental Immunology
1995
Corpus ID: 30505433
The expression of MHC class II antigens by peripheral blood monocytes from normal individuals was investigated. Class II…
Expand
1994
1994
The riminophenazine agents clofazimine and B669 reverse acquired multidrug resistance in a human lung cancer cell line.
C. V. van Rensburg
,
R. Anderson
,
M. Myer
,
G. Jooné
,
J. O'sullivan
Cancer Letters
1994
Corpus ID: 11829252
1993
1993
Clofazimine and B669 inhibit the proliferative responses and Na+, K(+)-adenosine triphosphatase activity of human lymphocytes by a lysophospholipid-dependent mechanism.
R. Anderson
,
M. J. Smit
Biochemical Pharmacology
1993
Corpus ID: 22129620
Highly Cited
1993
Highly Cited
1993
The riminophenazine agents clofazimine and B669 inhibit the proliferation of cancer cell lines in vitro by phospholipase A2-mediated oxidative and nonoxidative mechanisms.
C. V. van Rensburg
,
A. M. van Staden
,
R. Anderson
Cancer Research
1993
Corpus ID: 34869482
Clofazimine, a riminophenazine antimicrobial agent, and its analogue B669 were investigated for their effects on FaDu cells, a…
Expand
Highly Cited
1992
Highly Cited
1992
Antimicrobial activities of clofazimine and B669 are mediated by lysophospholipids
C. V. van Rensburg
,
G. Jooné
,
J. O'sullivan
,
R. Anderson
Antimicrobial Agents and Chemotherapy
1992
Corpus ID: 28109364
The susceptibilities of a range of gram-positive and gram-negative microbial pathogens to clofazimine and its analog B669 (0.1 to…
Expand
1989
1989
Investigation of the structural properties of dihydrophenazines which contribute to their pro-oxidative interactions with human phagocytes.
J. Savage
,
J. F. O'sullivan
,
B. Zeis
,
R. Anderson
Journal of Antimicrobial Chemotherapy
1989
Corpus ID: 38994159
Twenty-six dihydrophenazine compounds, including clofazimine, were investigated, at a fixed concentration of 1 mg/l, for their…
Expand
Review
1986
Review
1986
Bacterial periplasmic transport systems: structure, mechanism, and evolution.
G. F. Ames
Annual Review of Biochemistry
1986
Corpus ID: 8499820
RAHAL J1. Effect of combined therapy with ansamycin, clofazimine, ethambutol, and isoniazid for Mycobacterium avium infection in…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE